513.36

0.42% -2.19

After Hours: 513.36

Idexx Laboratories Inc (IDXX)

Overview News Price History Option Chain Financials Why IDXX Down? Discussions Forecast Stock Split

Idexx Laboratories Inc stock is traded at $513.36, with a volume of 1.32M. It is down -0.42% in the last 24 hours and up +17.48% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Previous Close:

$515.55

Open:

$514.27

24h Volume:

1.32M

Relative Volume:

1.61

Market Cap:

$41.28B

Revenue:

$3.93B

Net Income/Loss:

$894.97M

P/E Ratio:

47.45

EPS:

10.82

Net Cash Flow:

$837.70M

1W Performance:

+2.35%

1M Performance:

+17.48%

6M Performance:

+21.72%

1Y Performance:

+2.72%

1-Day Range:

$506.28

$515.92

1-Week Range:

$505.81

$520.00

52-Week Range:

$356.14

$530.60

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name

Idexx Laboratories Inc

Sector

Healthcare (1170)

Industry

Diagnostics & Research (56)

Phone

(207) 556-0300

Address

ONE IDEXX DRIVE, WESTBROOK, ME

Employee

11,000

Twitter

@idexx

Next Earnings Date

2025-02-03

Latest SEC Filings

IDXX's Discussions on Twitter

Compare IDXX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IDXX Idexx Laboratories Inc	513.36	40.34B	3.93B	894.97M	837.70M	10.82
TMO Thermo Fisher Scientific Inc	402.82	148.60B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	189.90	132.07B	23.82B	3.77B	4.90B	5.15
A Agilent Technologies Inc	111.92	30.82B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	140.33	23.70B	15.50B	1.33B	2.16B	7.34

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-24	Initiated	Leerink Partners	Outperform
Jul-25-24	Initiated	BTIG Research	Buy
Jan-30-24	Downgrade	Piper Sandler	Overweight → Neutral
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Dec-04-23	Upgrade	Cleveland Research	Neutral → Buy
Aug-02-23	Downgrade	Atlantic Equities	Overweight → Neutral
Jul-25-22	Downgrade	Stifel	Buy → Hold
Jul-21-22	Upgrade	Goldman	Neutral → Buy
Jul-12-22	Initiated	Piper Sandler	Overweight
May-05-22	Downgrade	BofA Securities	Buy → Neutral
Feb-08-22	Initiated	Atlantic Equities	Overweight
Nov-18-21	Initiated	Morgan Stanley	Overweight
Aug-05-21	Resumed	Credit Suisse	Outperform
Jul-12-21	Downgrade	Guggenheim	Buy → Neutral
Feb-17-21	Initiated	Barclays	Overweight
Sep-09-19	Initiated	Goldman	Neutral
May-23-19	Initiated	Guggenheim	Buy
Nov-02-18	Reiterated	BofA/Merrill	Buy
May-07-18	Reiterated	Stifel	Buy
Jan-16-18	Initiated	Piper Jaffray	Overweight
Aug-23-17	Upgrade	BofA/Merrill	Neutral → Buy
Jul-28-17	Upgrade	CL King	Neutral → Buy
Feb-03-17	Downgrade	Feltl & Co.	Hold → Sell
Sep-29-16	Resumed	BofA/Merrill	Neutral
Aug-16-16	Reiterated	Stifel	Buy
Aug-03-16	Upgrade	Northcoast	Sell → Neutral
Jul-20-16	Reiterated	Canaccord Genuity	Buy
Apr-19-16	Reiterated	Canaccord Genuity	Buy
Apr-01-16	Initiated	CL King	Neutral
Mar-21-16	Reiterated	Stifel	Buy
Feb-04-16	Initiated	Credit Suisse	Outperform
Oct-29-15	Reiterated	Stifel	Buy
Aug-28-15	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-13-15	Reiterated	Stifel	Buy
Jul-23-15	Reiterated	Canaccord Genuity	Buy

View All

Idexx Laboratories Inc Stock (IDXX) Latest News

May 29, 2025

Companion Animal Diagnostics Market Is Booming WorldwideIDEXX Laboratories, Heska Corporation - openPR.com

May 29, 2025

May 28, 2025

Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10 - marketscreener.com

May 28, 2025

IDEXX Laboratories To Present At Stifel Jaws & Paws Conference; Webcast At 10:55 AM ET - Nasdaq

May 28, 2025

May 27, 2025

IDEXX Laboratories Stock: Analyst Estimates & Ratings - MSN

May 27, 2025

May 26, 2025

IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st

May 26, 2025

May 23, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

May 23, 2025

May 21, 2025

IDEXX Lab jumps after Q1 beat and guidance raise - MSN

May 21, 2025

May 20, 2025

IDEXX Laboratories (NASDAQ:IDXX) Given New $510.00 Price Target at Stifel Nicolaus - Defense World

May 20, 2025

May 19, 2025

IDEXX Laboratories (IDXX) Target Price Raised by Stifel to $510 | IDXX Stock News - GuruFocus

May 19, 2025

If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance

May 19, 2025

Idexx Laboratories (IDXX) Price Target Increased by Stifel Analy - GuruFocus

May 19, 2025

Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $460, Maintains Hold Rating - marketscreener.com

May 19, 2025

May 15, 2025

5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil - TradingView

May 15, 2025

May 14, 2025

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits (NASDAQ:IDXX) - Seeking Alpha

May 14, 2025

Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

May 14, 2025

May 13, 2025

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day | IDXX Stock News - GuruFocus

May 13, 2025

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day - Business Wire

May 13, 2025

May 12, 2025

BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $577 From $566, Maintains Outperform Rating - marketscreener.com

May 12, 2025

IDEXX Laboratories (NASDAQ:IDXX) Upgraded at StockNews.com - Defense World

May 12, 2025

May 11, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable - simplywall.st

May 11, 2025

May 10, 2025

Idexx outlines 2025 growth with 6-9% organic revenue target amid innovation launches - MSN

May 10, 2025

May 09, 2025

IDEXX Laboratories (IDXX) Announces Key Amendments to Corporate Structure - GuruFocus

May 09, 2025

IDEXX Laboratories Updates Corporate Governance Structure - TipRanks

May 09, 2025

May 08, 2025

Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey

May 08, 2025

May 06, 2025

IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $558.00 at Morgan Stanley - Defense World

May 06, 2025

Rep. April McClain Delaney Buys IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - Defense World

May 06, 2025

May 05, 2025

IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus

May 05, 2025

BTIG Raises Price Target on IDEXX Laboratories to $545 From $530, Maintains Buy Rating - marketscreener.com

May 05, 2025

Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $558 From $548, Maintains Overweight Rating - marketscreener.com

May 05, 2025

May 03, 2025

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript - Insider Monkey

May 03, 2025

May 02, 2025

IDEXX Laboratories Ups Profit Forecast Thanks To Pet Care Demand - Finimize

May 02, 2025

IDEXX Laboratories [NasdaqGS:IDXX] Raises 2025 Guidance and Reports Q1 Growth in Revenue and EPS - Yahoo Finance

May 02, 2025

Leerink Partners Adjusts IDEXX Laboratories Price Target to $515 From $500 - marketscreener.com

May 02, 2025

IDEXX Laboratories Announces First Quarter Results | IDXX Stock News - GuruFocus

May 02, 2025

IDEXX Laboratories (IDXX) Surpasses Q1 Expectations with Robust Earnings - GuruFocus

May 02, 2025